FDA PDUFA Calendar: Drug Approval Dates & Deadlines
Track FDA PDUFA dates for NDA, BLA, ANDA, and IND decisions. Free drug approval tracker with source-linked deadlines, calendar views, and daily updates.
Published PDUFA target action dates for NDAs, BLAs, ANDAs, and INDs scheduled in the next 90 days, sourced from FDA primary records and updated daily.
Tracking 26 published FDA PDUFA decisions, including 16 NDAs and 10 BLAs.
| Sponsor | Product | Type | Application | PDUFA date | Status |
|---|---|---|---|---|---|
| Eisai and Biogen | LEQEMBI IQLIK | BLA | PENDING-provisional|eisaiandbiogen|leqembiiqlik|subcutan | upcoming | |
| MannKind | Afrezza | BLA | PENDING-provisional|mannkind|afrezza|diabetesinchildrena | upcoming | |
| Cingulate | CTx-1301 | NDA | PENDING-provisional|cingulate|ctx1301|attentiondeficithy | upcoming | |
| Daiichi Sankyo and AstraZeneca | DATROWAY | BLA | PENDING-provisional|daiichisankyoandastrazeneca|datroway | upcoming | |
| Arvinas | vepdegestrant | NDA | PENDING-provisional|arvinas|vepdegestrant|esr1mutatederp | upcoming | |
| GSK and Spero Therapeutics | tebipenem HBr | NDA | PENDING-provisional|gskandsperotherapeutics|tebipenemhbr | upcoming | |
| Merck | KEYTRUDA + WELIREG | BLA | PENDING-provisional|merck|keytrudawelireg|adjuvanttreatm | upcoming | |
| Arcutis Biotherapeutics | ZORYVE cream 0.3% | NDA | PENDING-provisional|arcutisbiotherapeutics|zoryvecream03 | upcoming | |
| Lantheus | LNTH-2501 (Ga 68 edotreotide) | NDA | PENDING-provisional|lantheus|lnth2501ga68edotreotide|pet | upcoming | |
| Unicycive Therapeutics | oxylanthanum carbonate | NDA | PENDING-provisional|unicycivetherapeutics|oxylanthanumca | upcoming | |
| Ionis Pharmaceuticals | olezarsen | NDA | PENDING-provisional|ionispharmaceuticals|olezarsen|sever | upcoming | |
| Viridian Therapeutics | veligrotug | BLA | PENDING-provisional|viridiantherapeutics|veligrotug|thyr | upcoming | |
| Ascelia Pharma | Orviglance | NDA | PENDING-provisional|asceliapharma|orviglance|liverimagin | upcoming | |
| Vera Therapeutics | atacicept | BLA | PENDING-provisional|veratherapeutics|atacicept|iganephro | upcoming | |
| Daiichi Sankyo and AstraZeneca | ENHERTU | BLA | PENDING-provisional|daiichisankyoandastrazeneca|enhertu| | upcoming | |
| Corcept Therapeutics | relacorilant + nab-paclitaxel | NDA | PENDING-provisional|corcepttherapeutics|relacorilantnabp | upcoming | |
| Celcuity | gedatolisib | NDA | PENDING-provisional|celcuity|gedatolisib|hrpositiveher2n | upcoming | |
| Elevar Therapeutics | rivoceranib + camrelizumab | NDA | PENDING-provisional|elevartherapeutics|rivoceranibcamrel | upcoming | |
| Sanofi | Sarclisa SC | BLA | PENDING-provisional|sanofi|sarclisasc|multiplemyeloma|20 | upcoming | |
| Otsuka Pharmaceutical | centanafadine | NDA | PENDING-provisional|otsukapharmaceutical|centanafadine|a | upcoming | |
| MannKind | FUROSCIX ReadyFlow Autoinjector | NDA | PENDING-provisional|mannkind|furoscixreadyflowautoinject | upcoming | |
| Viatris | low-dose estrogen weekly patch | NDA | PENDING-provisional|viatris|lowdoseestrogenweeklypatch|c | upcoming | |
| Moderna | mRNA-1010 | BLA | PENDING-provisional|moderna|mrna1010|seasonalinfluenzapr | upcoming | |
| Lantheus | MK-6240 | NDA | PENDING-provisional|lantheus|mk6240|petimagingagenttarge | upcoming | |
| Bristol Myers Squibb | iberdomide + daratumumab/dexamethasone | NDA | PENDING-provisional|bristolmyerssquibb|iberdomidedaratum | upcoming | |
| Merck, Astellas, and Pfizer | KEYTRUDA + PADCEV | BLA | PENDING-provisional|merckastellasandpfizer|keytrudapadce | upcoming |
Use the calendar, timeline, status board, or table views above to filter, sort, and inspect source-linked details.
Track FDA PDUFA dates for NDA, BLA, ANDA, and IND decisions. Free drug approval tracker with source-linked deadlines, calendar views, and daily updates.